EX-23.3 5 ex23_327jun2014.htm EXHIBIT 23.3
Exhibit 23.3
 
 
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated March 15, 2012 relating to the financial statements which appears in Progenics Pharmaceuticals, Inc.'s Annual Report on Form 10-K for the year ended December 31, 2013.


/s/ PricewaterhouseCoopers LLP

PricewaterhouseCoopers LLP
New York, New York
June 27, 2014